Sebastian Brunemeier

Sebastian Brunemeier is the Co-founder and General Partner at Healthspan Capital and the Co-founder and Chief Executive Officer at ImmuneAgeBio. He previously served as Co-founder and Chief Investment Officer at Cambrian Biopharma and Co-founder and Chief Operating Officer at Samsara Therapeutics, contributing to the creation of four longevity biotech companies with a combined equity value exceeding $600 million. Additionally, Brunemeier worked as a Principal at Apollo Health Ventures, where he helped manage a $200 million fund, and currently acts as a Venture Scout for Picus Capital. His academic training includes an MSc and DPhil (ABD) in the biochemistry of aging from Oxford University, and he has held advisory roles at McKinsey & Company and VitaDAO. Brunemeier focuses his venture investments and entrepreneurial efforts on longevity biotechnology, geroscience, and regenerative medicine to extend human healthspan.